Biotalys Obtains Subscription Commitments for EUR 12.05 Million through a Private Placement of New Shares with Current Investors
Ghent, BELGIUM – 6 May 2026, 07:00 CEST – Biotalys (Euronext: BTLS) (the “Company” or “Biotalys”), today announced it has successfully obtained subscription commitments for new shares for an amount of EUR 12,050,000 through a private placement (“Private Placement”).
The Private Placement involves the issue of 7,875,811 new shares (rounded 20.96% of the Company’s shares outstanding prior to the transaction) at an issue price of EUR 1.53 per share, representing a discount of 40% compared to the volume weighted average price of the Company’s share on Euronext Brussels during the period of 30 days from (and including) 1 April 2026 till (and including) 30 April 2026.
Investors participating in the Private Placement are current shareholders, including Ackermans & van Haaren NV, Agri Investment Fund BV, ASR Vermogensbeheer NV, Federale Participatie- en Investeringsmaatschappij NV, GIMV NV, PMV NV, Sofinnova Industrial Biotech I, and the Flemish Institute for Biotechnology VIB.
Simon Moroney, Chairman of Biotalys, said: “On behalf of the board, I welcome this additional financing by our long-term reference shareholders. These investors support our view that there’s an urgent and growing need for safe, efficacious and cost-competitive biocontrol solutions that can replace conventional chemistry. This investment reflects a conviction that our technology is well- positioned to address this need and that scalable, fermentation-based biocontrols are essential to the future of sustainable crop protection.”
Carlo Boutton, interim CEO of Biotalys, commented: “We are grateful for the continued confidence and commitment shown by our key investors through this capital raise. Their support enables Biotalys to develop its unique precision biocontrol solutions and bring these to growers, starting with the U.S. and Europe. With this strengthened capital base, we are well positioned to advance our innovative pipeline and create sustainable value for agriculture and its stakeholders. We look forward to building the future of crop protection together.”
Biotalys is developing precision biocontrol solutions based on proteins for the protection of crops in both the pre- and post-harvest markets. The Company provides novel solutions that bridge the efficacy and scale of chemistry with the environmental advantages of biological solutions. Based on its novel AGROBODY™ technology platform, Biotalys is developing a focused pipeline of effective product candidates with a favorable safety profile that aim to address key crop pests and diseases across the whole value chain, from soil to plate.